insights_auto
Zašto je NVZMY skočio 2,26%?
Istražite detaljnijechevron_right
NVZMY:OTCMKTS
NOVONESIS NOVOZYMES B Unsponsored Denmark ADR
68,62 USD
arrow_upward
+2,26%(+1,52) 1D
15. lis, 13:47:24 GMT -4 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za NVZMY...
Otvori
69,05 USD
Najviša
69,15 USD
Najniža
68,49 USD
Trž. kap.
183,47 mlr.
Prosj. kol.
22,98 tis.
Količina
16,15 tis.
52-tjed. najviša
75,26 USD
52-tjed. najniža
49,90 USD
Beta
0,87
Dionice u optjecaju
414,56 mil.
Broj djelatnika
11 tis.
Otvori
69,05 USD
Najviša
69,15 USD
Najniža
68,49 USD
Trž. kap.
183,47 mlr.
Prosj. kol.
22,98 tis.
Količina
16,15 tis.
52-tjed. najviša
75,26 USD
52-tjed. najniža
49,90 USD
Beta
0,87
Dionice u optjecaju
414,56 mil.
Broj djelatnika
11 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
ad-hoc-news.de
·
prije 6 sati
Novonesis stock stands 1.27 percent below its 52-week high
Profil
Novonesis is a biotechnology company headquartered in Lyngby, Denmark. Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen.
The company develops enzymes, microbial cultures, and other biological products used in food and beverage production, household products, agriculture, and bioenergy.
The merger, first announced in December 2022, was the largest merger in history between two Danish companies. It would combine Novozymes' industrial-enzyme business with Chr. Hansen's microbial cultures and food-ingredient operations.
The company is publicly traded on Nasdaq Copenhagen and is part of the OMX Copenhagen 25 Index. The company's largest shareholder is Novo Holdings A/S, which is owned by the Novo Nordisk Foundation.
As of 2025, Novonesis has more than 11,000 employees and activities in over 45 countries. Wikipedia
NOVONESIS NOVOZYMES B Unsponsored Denmark ADR – informacije
Glavni izvršni direktorEster Baiget
Zaposlenici11,1 tis.
Osnovano2000
Sjedište-
SektorSpeciality chemicals
Web-lokacijanovonesis.com